Methods Proportions of patients reaching three endpoints were taken from SUSTAIN 3 and 7 for comparisons with exenatide ER and dulaglutide, respectively
Non-prespecified outcomes included fat mass, lean soft tissue mass, lean soft tissue mass (%), BMI and HR
What is the typical starting dose of Rybelsus (semaglutide)
THERMOGENIC SUPPORT FOR FAT BURNING: Featuring MitoBurn and CaloriBurn GP, our thermogenic fat burner activates Brown Adipose Tissue (BAT), enhancing thermogenesis to boost calorie burning and convert stored fat into fuel, helping you reach your fitness goals more effectively
The weight loss results exceed anything weve seen before in pharmaceutical obesity treatment
The longer estimate (30 days) represents the outer limit